MedTrace Logo

Safety and Performance Study of the CAdiscTM-L Lumbar Spinal Disc Replacement Device For CE Marking

NCT00949936 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2010-10-15

No results posted yet for this study

Summary

The purpose of this European Union (EU) study to evaluate the safety and performance of the CAdiscTM-L Lumbar Spinal Disc Replacement Device in the surgical replacement of the lumbar intervertebral discs (L3 to S1) for patients requiring surgical intervention for total lumbar disc replacement for the treatment of debilitating, chronic low back pain.

Conditions

  • Chronic Low Back Pain
  • Lumbar Degenerative Disc Disease

Interventions

DEVICE

CAdisc™-L (Total Disc Replacement)

Sponsors & Collaborators

  • Ranier Technology Limited

    lead INDUSTRY

Study Design

Purpose
TREATMENT

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Completion
2010-06-30

Countries

  • Belgium
  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00949936 on ClinicalTrials.gov